Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy

Transplantation

Volumn 64, Issue 6, 1997, Pages 848-852

  Darenkov, Ivan A ^a   Marcarelli, Margaret A ^a   Basadonna, Giacomo P ^a   Friedman, Amy L ^a   Lorber, Kathleen M ^a   Howe, John G ^a   Crouch, Jill ^a   Bia, Margaret J ^a   Kliger, Alan S ^a   Lorber, Marc I ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; GANCICLOVIR; LYMPHOCYTE ANTIBODY; OKT 3; THYMOCYTE ANTIBODY;

ANTIVIRAL ACTIVITY; ARTICLE; CELL PROLIFERATION; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GRAFT REJECTION; HUMAN; IMMUNOFLUORESCENCE; INCIDENCE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MONITORING; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RISK ASSESSMENT;

ACYCLOVIR; ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, CD19; ANTILYMPHOCYTE SERUM; ANTIVIRAL AGENTS; GANCICLOVIR; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MIDDLE AGED; MUROMONAB-CD3; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 0030863440     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199709270-00010     Document Type: Article

References (30)

1. Hanto DW, Gajl-Peczalska KJ, Frizzera G, et al. Epstein Barr virus induced polyclonal and monoclonal B cell lymphoproliferative diseases occurring after renal transplantation: clinical, pathologic, and virologic findings and implications for therapy. Ann Surg 1983; 198: 356.
2. Starzl TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine A-prednisone immunosuppression. Lancet 1984; 1: 583.
3. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133: 173.
4. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 1990; 323: 1723.
5. Morrissey PE, Lorber KM, Marcarelli M, et al. Posttransplant Epstein-Barr virus infection is associated with elevated levels of CD19+ B lymphocytes. Transplantation 1995; 59: 637.
6. Hanto DW, Grizzera G, Purtilo DT, et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein Barr virus. Cancer Res 1981; 41: 4253.
7. Bia MJ, Flye MW. Immunoblastic lymphoma in a cyclosporine treated renal transplant recipient. Transplantation 1985; 39: 673.
8. Randhawa PS, Jaffe R, Demetris AJ, et al. Expression of Epstein Barr virus-encoded small RNA in liver specimens from transplant recipients with PTLD. N Engl J Med 1992; 327: 1710.
9. Stephanian E, Gruber SA, Dunn DL, Matas AJ. Posttransplant lymphoproliferative disorders. Transplant Rev 1991; 5: 120.
10. First MR. Long term complications after transplantation. Am J Kidney Dis 1993; 22: 477.
11. Davis CL, Harrison KL, McVicar JP, et al. Antiviral prophylaxis and EBV related posttransplant lymphoproliferative disorder. Clin Transplant 1995; 9: 53.
12. Kuo PC, Dafoe DC, Alfrey EJ, et al. Posttransplant lymphoproliferative disorders and Epstein-Barr virus prophylaxis. Transplantation 1995; 59: 135.
13. Hibberd PL, Tolkoff-Rubin NE, Conti D, et al. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody positive renal transplant recipients. Ann Intern Med 1995; 123: 18.
14. Lin J-C, Smith MC, Pagano JS. Prolonged inhibitory effect of 9-(1,3-dihydroxy-2- propoxymethyl) guanine against replication of Epstein- Barr virus. J Virol 1984; 50: 50.
15. Chang KL, Chen YY, Shibata D, Weiss LM. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diag Mol Pathol 1992; 1: 246.
16. Purtilo DT. Epstein Barr virus induced oncogenesis in immunodeficient individuals. Lancet 1980; 1: 300.
17. Schmidt GM, Horak DA, Niland JC, et al. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med 1991; 324: 1005.
18. Rubin RH. Preemptive therapy in immunocompromised hosts. N Engl J Med 1991; 324: 1057.
19. Cockfield SM, Preiksaitis JK, Jewell LD, Parfrey NA. Post transplant lymphoproliferative disorder in renal allograft recipients. Transplantation 1993; 56: 88.
20. Walker RC, Paya CV, Marshall WF, et al. Pretransplant sero-negative EBV status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung and other solid organ transplantations. J Heart Lung Trans 1995; 14: 214.
21. Newell KA, Alonso EM, Whitington PF, et al. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Transplantation 1996; 62: 370.
22. Aris RM, Maia DM, Neuringer IP, et al. Post transplant lymphoproliferative disorder in the EBV naive lung transplant recipient. Am J Respir Crit Care Med 1996; 154: 1712.
23. Birkland SA, Hamilton-Dutoit S, Sandvej K, et al. EBV induced post transplant lymphoproliferative disorder. Transplant Proc 1995; 27: 3467.
24. Haque T, Thomas JA, Falk KI, et al. Transmission of donor Epstein-Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients. J Gen Virol 1996; 77: 1169.
25. Nalesnik MA. Posttransplantation lymphoproliferative disorders; current perspectives. Semin Thor Cardiovasc Surg 1996; 8: 139.
26. Hanto DW, Frizzera G, Gajl-Peczalska KJ, et al. Acyclovir therapy of EBV induced post transplant lymphoproliferative diseases. Transplant Proc 1985; 17: 89.
27. Pirsch JD, Stratta RJ, Sollinger HW, et al. Treatment of severe EBV induced lymphoproliferative syndrome with ganciclovir. Am J Med 1989; 86: 241.
28. Lien Y-H, Schroter GPJ, Weil R III, et al. Complete remission and possible immune tolerance after multidrug combination chemotherapy for cyclosporine related lymphoma in a renal transplant recipient with acute pancreatitis. Transplantation 1991; 52: 739.
29. Mihalov ML, Gattuso P, Abraham K, et al. Incidence of posttransplant malignancy among 674 solid-organ-transplant recipients at a single center. Clin Transplant 1996; 10: 248.
30. Swinnen LJ, Mullen GM, Carr TJ, et al. Aggressive treatment for postcardiac transplant lymphoproliferation. Blood 1995; 86: 3333.